{ "cik": 1367644, "cik_padded": "0001367644", "entityName": "Emergent BioSolutions Inc.", "fiscal_years": [ { "accn": "0001367644-26-000015", "filed": "2026-02-27", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 24900000.0, "capex": 13800000.0, "cash": 205400000.0, "eps_diluted": 0.93, "free_cash_flow": 156800000.0, "net_income": 52600000.0, "operating_cash_flow": 170600000.0, "operating_income": 100100000.0, "revenue": 742900000.0, "stockholders_equity": 522600000.0, "total_assets": 1318600000.0, "total_liabilities": 796000000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.523153463451971, "net_margin": 0.0708036074841836, "operating_margin": 0.13474222641001482, "revenue_growth_yoy": -0.2881372173246455, "roa_avg2y": 0.03884355499759997, "roa_period_end": 0.03989079326558471, "roe_avg2y": 0.1046349711557589, "roe_period_end": 0.10065059318790662 } }, { "accn": "0001367644-26-000015", "filed": "2026-02-27", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 22900000.0, "cash": 99500000.0, "eps_diluted": -3.6, "free_cash_flow": 35800000.0, "net_income": -190600000.0, "operating_cash_flow": 58700000.0, "operating_income": -108700000.0, "revenue": 1043600000.0, "stockholders_equity": 482800000.0, "total_assets": 1389700000.0, "total_liabilities": 906900000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.8784175642087821, "net_margin": -0.1826370256803373, "operating_margin": -0.10415868148715983, "revenue_growth_yoy": -0.005432192890498427, "roa_avg2y": -0.11864670546857979, "roa_period_end": -0.13715190328847954, "roe_avg2y": -0.33671937108029326, "roe_period_end": -0.3947804473902237 } }, { "accn": "0001367644-26-000015", "filed": "2026-02-27", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 51600000.0, "cash": 111700000.0, "eps_diluted": -14.85, "free_cash_flow": -257900000.0, "net_income": -760500000.0, "operating_cash_flow": -206300000.0, "operating_income": -726400000.0, "revenue": 1049300000.0, "stockholders_equity": 649300000.0, "total_assets": 1823200000.0, "total_liabilities": 1173900000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.8079470198675496, "net_margin": -0.7247688935480796, "operating_margin": -0.6922710378347471, "revenue_growth_yoy": -0.06102908277404922, "roa_avg2y": -0.3048401643451248, "roa_period_end": -0.4171237384817903, "roe_avg2y": -0.7466863033873343, "roe_period_end": -1.1712613583859541 } }, { "accn": "0001367644-26-000015", "filed": "2026-02-27", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 82100000.0, "capex": 115800000.0, "cash": 642600000.0, "eps_diluted": -4.22, "free_cash_flow": -149900000.0, "net_income": -211600000.0, "operating_cash_flow": -34100000.0, "operating_income": -170000000.0, "revenue": 1117500000.0, "stockholders_equity": 1387700000.0, "total_assets": 3166300000.0, "total_liabilities": 1778600000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.2816891258917633, "net_margin": -0.18935123042505592, "operating_margin": -0.15212527964205816, "revenue_growth_yoy": -0.3699255751014885, "roa_avg2y": -0.06910516002612671, "roa_period_end": -0.0668287907020813, "roe_avg2y": -0.1411042944785276, "roe_period_end": -0.15248252504143547 } }, { "accn": "0001367644-25-000021", "filed": "2025-03-04", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 106000000.0, "capex": 224100000.0, "cash": 576100000.0, "eps_diluted": 4.06, "free_cash_flow": 96100000.0, "net_income": 219500000.0, "operating_cash_flow": 320200000.0, "operating_income": 341400000.0, "revenue": 1773600000.0, "stockholders_equity": 1611500000.0, "total_assets": 2957700000.0, "total_liabilities": 1346200000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.8353707725721378, "net_margin": 0.12375958502480829, "operating_margin": 0.19248985115020298, "revenue_growth_yoy": 0.12445317948392823, "roa_avg2y": 0.07515965005393005, "roa_period_end": 0.07421307096730567, "roe_avg2y": 0.1433516196447231, "roe_period_end": 0.1362085013962147 } }, { "accn": "0001367644-24-000033", "filed": "2024-03-08", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 141900000.0, "cash": 621300000.0, "eps_diluted": 5.68, "free_cash_flow": 395000000.0, "net_income": 305800000.0, "operating_cash_flow": 536900000.0, "operating_income": 438500000.0, "revenue": 1577300000.0, "stockholders_equity": 1450900000.0, "total_assets": 2883200000.0, "total_liabilities": 1436200000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.9898683575711628, "net_margin": 0.1938756102199962, "operating_margin": 0.27800672034489315, "revenue_growth_yoy": 0.42613019891500903, "roa_avg2y": 0.11737837059783131, "roa_period_end": 0.10606270810210877, "roe_avg2y": 0.2405790260404374, "roe_period_end": 0.21076573161485976 } }, { "accn": "0001367644-23-000207", "filed": "2023-12-11", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 86900000.0, "cash": 167800000.0, "eps_diluted": 1.04, "free_cash_flow": 101100000.0, "net_income": 54500000.0, "operating_cash_flow": 188000000.0, "operating_income": 114100000.0, "revenue": 1106000000.0, "stockholders_equity": 1091300000.0, "total_assets": 2327300000.0, "total_liabilities": 1238800000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.1351599010354623, "net_margin": 0.049276672694394216, "operating_margin": 0.10316455696202531, "roa_avg2y": 0.023920819891588212, "roa_period_end": 0.023417694323894643, "roe_avg2y": 0.051850442393682805, "roe_period_end": 0.04994043800971318 } }, { "accn": "0001367644-22-000024", "filed": "2022-02-25", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 100000.0, "capex": 72100000.0, "cash": 112200000.0, "eps_diluted": 1.22, "free_cash_flow": -30300000.0, "net_income": 62700000.0, "operating_cash_flow": 41800000.0, "operating_income": 89800000.0, "stockholders_equity": 1010900000.0, "total_assets": 2229400000.0, "total_liabilities": 1218500000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.2053615590068256, "roa_avg2y": 0.03800460661898412, "roa_period_end": 0.028124158966538082, "roe_avg2y": 0.06520382695507487, "roe_period_end": 0.062023939064200215 } }, { "accn": "0001367644-21-000033", "filed": "2021-02-19", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 33100000.0, "capex": 54800000.0, "cash": 178300000.0, "eps_diluted": 1.71, "free_cash_flow": 153300000.0, "net_income": 82600000.0, "operating_cash_flow": 208100000.0, "operating_income": 124300000.0, "stockholders_equity": 912300000.0, "total_assets": 1070200000.0, "total_liabilities": 157900000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.17307903102049765, "roa_avg2y": 0.08096804849848871, "roa_period_end": 0.07718183517099607, "roe_avg2y": 0.10951276102088167, "roe_period_end": 0.09054039241477584 } }, { "accn": "0001367644-20-000010", "filed": "2020-02-25", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 76200000.0, "cash": 271500000.0, "eps_diluted": 1.13, "free_cash_flow": -21600000.0, "net_income": 51800000.0, "operating_cash_flow": 54600000.0, "operating_income": 105500000.0, "stockholders_equity": 596200000.0, "total_assets": 970111000.0, "total_liabilities": 373906000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6271486078497148, "roa_period_end": 0.05339595159729145, "roe_period_end": 0.08688359610868837 } }, { "accn": "0001367644-16-000059", "filed": "2016-02-29", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "revenue": "USD" }, "fundamentals": { "revenue": 522789000.0 }, "period_end": "2015-12-31", "ratio_units": { "revenue_growth_yoy": "ratio" }, "ratios": { "revenue_growth_yoy": 0.16139717153406288 } }, { "accn": "0001367644-16-000059", "filed": "2016-02-29", "fiscal_year": 2014, "form": "10-K", "fundamental_units": { "revenue": "USD" }, "fundamentals": { "revenue": 450138000.0 }, "period_end": "2014-12-31", "ratio_units": { "revenue_growth_yoy": "ratio" }, "ratios": { "revenue_growth_yoy": 0.43931317846808104 } }, { "accn": "0001367644-16-000059", "filed": "2016-02-29", "fiscal_year": 2013, "form": "10-K", "fundamental_units": { "revenue": "USD" }, "fundamentals": { "revenue": 312745000.0 }, "period_end": "2013-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001367644-26-000015", "filed": "2026-02-27", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001367644.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001367644.json" }, "ticker": "EBS" }